- Active Ingredients
Product Documentation
-
View RMM (Risk of miscarriage and birth defects: Patient Guide)
Last updated on this site: 10 May 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintMycophenolate mofetil 250mg Capsules
- PL Number:
- 20075/0097
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Summary of Product Characteristics (SmPC - Mycophenolate mofetil 250mg Capsules)
Last updated on this site: 11 Jul 2024
Update SmPC section 4.6 to implement the wording agreed by the CHMP following the outcome of the PSUR procedure EMEA/H/C/PSUSA/10550/202305.
View Patient Information Leaflet (PIL - Mycophenolate mofetil 250mg Capsules)Last updated on this site: 29 Jul 2025
The following change(s) has been notified:
1. Type IAIN (B.II.b.1.a) To add Accord Healthcare Single Member S.A., Greece as an alternative site responsible for secondary packaging site.
Type IAIN (B.II.b.2.C.2) To add Accord Healthcare Single Member S.A., Greece as an alternative site responsible for importation and batch release including batch control/testing of the finished product.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.